↓ Skip to main content

Phase I–II study of vorinostat plus paclitaxel and bevacizumab in metastatic breast cancer: evidence for vorinostat-induced tubulin acetylation and Hsp90 inhibition in vivo

Overview of attention for article published in Breast Cancer Research and Treatment, December 2011
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
74 Dimensions

Readers on

mendeley
69 Mendeley